New injection relieves symptoms of Crohn's disease

UCB's Cimzia has received Food & Drug Administration approval for treating Crohn's disease.

Crohn’s disease patients have a new monthly treatment option open to them. It’s UCB’s UCB claims Cimzia is the first and only PEGylated anti-tumor necrosis factor alpha antibody indicated for this